Nova Scotia pot business sees Q1 sales jump as more people stocked up on booze, cannabis 

Nova Scotia's provincially-owned liquor and cannabis business saw its first-quarter sales jump 5.3 per cent to $184 million as a result of pandemic-related spending. Cannabis accounted for about $17.3 million of that total, an improvement of 7.3 per cent from last year, the Nova Scotia Liquor Corporation (NSLC) said. The NSLC attributed the sales increase to the COVID-19 pandemic, which drove customers to purchase larger package sizes in order to make fewer trips to stores. In the quarter, the average dollar value of each cannabis-related transaction grew by 39.7 per cent to $49.91, the NSLC said. 

YSS sees Q2 revenue increase 12% to $4.7M, expects further growth next quarter

Canadian cannabis retailer YSS reported second-quarter results Wednesday, posting a 12-per-cent quarterly increase in revenue to $4.7 million. YSS, which operates 17 locations across Alberta and in Saskatchewan, also reported a net loss of $1.8 million in the quarter, slightly better than the $1.9 million it lost in the prior three-month period. YSS provided its full-year forecast on Wednesday, expecting revenue to exceed $5.6 million in its third quarter while predicting its gross margin should exceed $1.6 million.   

Vireo Health reports US$7.7M loss due to higher expenses

U.S. cannabis operator Vireo Health said Wednesday that its second-quarter revenue improved by 70 per cent over the past year to US$12.2 million, despite posting a US$7.7 million net loss. The company attributed the loss to rising operating expenses, notably share-based compensation related to a former executive who was terminated by the company. Vireo fired former Canopy Growth CEO Bruce Linton in June on a "without-cause" basis. Eight Capital analyst Graeme Kreindler raised his rating on Vireo to "buy" on Wednesday, noting that a key divestiture boosted the company’s cash position to US$21 million. 

Sign up for BNN Bloomberg's new weekly newsletter, Home Economics, which aims to help Canadians navigate their personal finances in the age of social distancing and beyond. Have it delivered to your inbox every Friday by subscribing at



"The elephants won't be using cannabis pipes, nor will they be getting huge barrels of it."

-- Polish veterinanian Agnieszka Czujkowska on a pilot project where elephants will be given medical marijuana to examine how it reduces their stress levels.  

Embedded Image

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the ongoing growth of the Canadian recreational cannabis industry. Read more here and subscribe to our Cannabis Canada newsletter to have the latest news delivered directly to your inbox every day.